KincaidPauly387

The researchers assessed four drugs: Allegra, Arava, Amaryl and Zithromax. In the next half 2005, each one of these drugs run out of patent protection. Their common equivalents were bought as an alternative at a typical factor of 87 percent within 1 month of the equivalents distribution at pharmacies.

The study was prepared by Medco Health Solutions Inc. Situated in Frankin Lakes, which is the largest drug benefit management company in U.S. The company offers for low prices of prescription drug with respect to its clients.

According to the study, Zithromax, the blockbuster of Pfizer Inc. with its annual sales of $1.85 million was quickly substituted at pharmacies by equivalent at a 90 percent rate soon after it lost its patent protection in November.

The analysis authors described the substitution of Zithromax, an for respiratory infections, as proof that more and more doctors recommend simple versions of brand drugs more quickly, even though it's about alleged acute treatment drugs, such as Zithromax.

The truly good news is these four generic medicines are simply the start. With numerous common medications likely to go off patent next several years, substantial prescription drug costs savings should be seen by us - explained a senior vice president, Dr. Glen Stettin.

A speaker at Medco, Ann Smith stated that more than 70 manufacturer drugs, including 19 blockbusters, are losing their patent protection next five years - with total annual sales of $45 million.

If Medcos study reveals a trend, in the coming years customers, companies and insurance firms will save billions of dollars in prescription drug - Smith said.

The information met with enthusiastic response from consumer groups.

Hopefully the pattern continues. Its good for consumers, revealed Bill Vaughan, senior coverage analyst for an group, Consumer Union, situated in Washington, D.C.

Vaughan described that past fears regarding the performance and safety of generic drugs have apparently started initially to disappear as society is now more concerned with rapid increase of health-care costs.

The FDA approves these generic drugs simply because they have already been decided just like safe and effective as their manufacturer counterparts, however you spend a fraction of the price, Vaughan said. We think this is very positive and can save your self customers literally billions of dollars in the next couple of years.

At once, large pharmaceutical companies have said that their brand name drugs will not be taken by reproductions as insurers and doctors understand that the brand name drugs guarantee better treatment and in effect - conserve money.

Hank McKinnell, Pfizer Chairman used that argument during last session with analysts in New York.

If you dont just like the high cost of medical care, try the high cost of vomiting, McKinnell suggested. diovan online investigation